InvestorsHub Logo
Followers 7
Posts 889
Boards Moderated 0
Alias Born 06/15/2015

Re: None

Thursday, 09/02/2021 8:10:24 AM

Thursday, September 02, 2021 8:10:24 AM

Post# of 46
XPro news also impressive. Data very.

“The data from this Phase I trial show that XPro decreases biomarkers of neuroinflammation and nerve cell death while improving biomarkers of neurorepair in patients with AD,” stated RJ Tesi, M.D., CEO of INmune Bio
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INMB News